Longitudinal Microperimetric Changes of Macular Sensitivity in Stargardt Disease After 12 Months
Open Access
- 1 July 2020
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Ophthalmology
- Vol. 138 (7) , 772-779
Abstract
Stargardt disease type 1 (STGD1) is caused by pathogenic mutations in the ABCA4 gene (OMIM 601691) and leads to atrophic-appearing macular lesions and variable loss of best-corrected visual acuity (BCVA),1 often from 20/20 to 20/400 or worse.2 BCVA remains the most commonly used functional end point in clinical trials for various retinal diseases. However, the Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) study recently showed that BCVA is unlikely to be a sensitive outcome measure in STGD1 except in certain subgroups because of the slow rate of BCVA loss.2,3 Conventional perimetry may not be appropriate for conditions that affect the fovea and lead to eccentric fixation.4 Fundus-controlled (micro)perimetry allows precise functional analysis of the macula by displaying stimuli in preplanned retinal areas.5 The MP-1 microperimeter is reliable for testing of macular function in STGD1.6 Point-by-point retest limits were determined to be ±4.2 dB and independent of the magnitude of overall measured sensitivity.6 We assessed longitudinal changes in microperimetric sensitivity during a 12-month period and their association with various parameters in patients with STGD1.Keywords
This publication has 28 references indexed in Scilit:
- Optic disc progression and rates of visual field change in treated glaucomaActa Ophthalmologica, 2013
- The Impact of Surgical Intraocular Pressure Reduction on Visual Function Using Various Criteria to Define Visual Field ProgressionJournal of Glaucoma, 2013
- Macular Function in Macular Degenerations: Repeatability of Microperimetry as a Potential Outcome Measure forABCA4-Associated Retinopathy TrialsInvestigative Ophthalmology & Visual Science, 2012
- NIDEK MP1 IS ABLE TO DETECT SUBTLE DECLINE IN FUNCTION IN INHERITED AND AGE-RELATED ATROPHIC MACULAR DISEASE WITH STABLE VISUAL ACUITYRetina, 2011
- Treatment of Geographic Atrophy by the Topical Administration of OT-551: Results of a Phase II Clinical TrialInvestigative Ophthalmology & Visual Science, 2010
- Test–Retest Variability of Microperimetry Using the Nidek MP1 in Patients with Macular DiseaseInvestigative Ophthalmology & Visual Science, 2009
- Reading Performance Is Reduced by Parafoveal Scotomas in Patients with Macular Telangiectasia Type 2Investigative Ophthalmology & Visual Science, 2009
- RETINAL FUNCTION AND LOSS OF AUTOFLUORESCENCE IN STARGARDT DISEASERetina, 2008
- WHAT YOU SEE IS NOT ALWAYS WHAT YOU GET IN ATROPHIC MACULAR DISEASERETINAL Cases & Brief Reports, 2008
- Microperimetric Assessment of Patients with Type 2 Idiopathic Macular TelangiectasiaInvestigative Ophthalmology & Visual Science, 2007